Ask AI

Downloadable Resource

Share

Program Content

Activities

  • PI3K/AKT Inhibitors in mBC
    PI3K/AKT Inhibitors in Patients With HR+/HER2- Metastatic Breast Cancer (mBC)
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 24, 2025

    Expires: April 23, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd.